1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

30 Jul 2024
Admin
News Article

USAID and Takeda Launch Dengue Prevention Campaign

USAID and Takeda launch dengue prevention campaign to help public safeguard from vector-borne diseases

Overview

United States Agency for International Development (USAID) and Takeda Biopharmaceuticals, the erstwhile Baxalta Bioscience India have launched a new campaign called ""Haarega Dengue Haraenge Hum (We Will Together Defeat Dengue).”

The Launch

The campaign was launched during the ‘Call to Action for Climate Sensitive Infectious Diseases: a Strategic Synergy Session’”, an event organized by CHRI under the USAID-supported Sustainable Action for Climate and Health (SACH) Initiative.

Campaign’s Focus

The focus is on educating school children and communities across Maharashtra, Odisha and Uttar Pradesh about how their actions can help prevent dengue.
It will also encourage people to adopt habits that can reduce the spread of vector-borne diseases.

On Vector-Borne Diseases

Due to the changing climate, specifically a rise in temperature and rainfall, vector-borne diseases are becoming more prevalent, adding additional stress to the already overwhelmed health systems from the recent pandemic.
The campaign will look deeper into how climate change affects the spread of infectious diseases and provide strategies to improve preparedness and build stronger and more responsive health systems in the country.

Statement from USAID

Warren Harrity, acting mission director, USAID, said, “We work to increase the resilience of the health systems by focusing on identifying shifts in climate-sensitive, vector-borne diseases through surveillance and early warning; strengthening health system capacity to prepare and respond to climate events; and supporting the development and implementation of climate-smart health policies.”

From the Embassy of Japan in India

Yamashita Yuta, first secretary (Health Attaché), Embassy of Japan in India, stated, “This collaboration for combating dengue represents a significant step in our shared commitment to global health and intensifies the Indo-Japan relationship.”
“Dengue has emerged as a critical threat to public health globally due to the emerged climatic unpredictability, and requires immediate addressal at local and international levels. Through our collective expertise and resources, we can make substantial progress in disease prevention and control, setting an example for international cooperation in healthcare.”

From Takeda Biopharmaceuticals India

Annapurna Das, general manager, Takeda Biopharmaceuticals India, noted that collective action is required from all sectors to accelerate efforts in the area of climate change to protect our communities from the impact of vector-borne diseases.
Protecting the climate is aligned with our purpose of bringing Better Health and a Brighter Future for all.
We are committed to this cause and will continue working with multiple stakeholders including the government, NGOs, industry, academia and healthcare providers to support the vision of Dengue Mukt Bharat.”

Words from CEO: CHRI

Neeraj Jain, chief executive officer, Centre for Health Research and Innovation (CHRI), said, “As 2024 is promoted as the ‘Year of Climate and Health Action,’ this partnership emphasizes the need for innovative approaches to fight climate-sensitive, infectious diseases."

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!